股票代码：002768 股票简称：国恩股份 公告编号：2023-031 青岛国恩科技股份有限公司 第五届监事会第二次会议决议公告 本公司及监事会全体成员保证信息披露内容的真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、监事会会议召开情况 表决结果：同意 3 票，反对 0 票，弃权 0 票。 三、备查文件 公司第五届监事会第二次会议决议。 青岛国恩科技股份有限公司（以下简称"公司"或"国恩股份"）第五届 监事会第二次会议于 2023 年 8 月 28 日 15:30 在公司办公楼四楼会议室召开。 本次会议由监事会主席王龙先生提议召开并主持，会议通知于 2023 年 8 月 18 日以专人送达形式发出。本次会议应到监事 3 名，实到监事 3 名。本次会议的 召集、召开和表决程序符合《中华人民共和国公司法》和《青岛国恩科技股份 有限公司章程》的有关规定，合法有效。 二、监事会会议审议情况 1、审议通过《关于〈公司 2023 年半年度报告全文及其摘要〉的议案》 经审核，董事会编制和审核公司 2023 年半年度报告的程序符合法律、行政 法规和中国证监会的规定，报告内容真实、准确、完整地反映了公司的实际情 ...

法定代表人： 主管会计工作的负责人： 会计机构负责人： | 非经营性资金占用 | 资金占用方名称 | 占用方与上市公司的 关联关系 | 上市公司 核算的会计科目 | 2023年期初 占用资金余额 | 2023年1-6占用累计发 生金额（不含利息） | 2023年1-6月 占用资金的利息 | 2023年1-6月 偿还累计发生金额 | 2023年6月末 占用资金余额 | 占用形成原因 | 占用性质 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 现大股东及其附属企业 | | | | | | | | | | | | 小计 | | | | | | | | | | | | 前大股东及其附属企业 | | | | | | | | | | | | 小计 | | | | | | | | | | | | 总计 | | | | | | | | | | | | | | 往来方与上市公司的 | 上市公司 | 2023年期初 | 2023年1-6占用累计发 | 2023年1-6月 | 2023年1-6月 | 2023年6月末 | | | | ...

| --- | --- | --- | |-------|-----------------------|----------------------| | 投 资 | □特定对象调研 | □分析师会议 | | 者 关 | □ | 媒体采访 √业绩说明会 | | 系 活 | □新闻发布会 □路演活动 | | | 动 类 | □现场参观 | | 别 □其他（请文字说明其他活动内容） | --- | --- | |-------|--------------------------------------------------------------| | | 公司董事长兼总经理王爱国先生、公司副总经理兼财务总监于垂柏先 | | | 生、公司副总经理兼董事会秘书于雨女士、独立董事王亚平先生、通 | | | 过全景网"投资者关系互动平台"（https://ir.p5w.net）参与本次年 | | | 度业绩说明会的投资者。 | | 时间 | 2023 年 6 月 7 日（星期三）15:00-16:30 | | 地点 | 全景网"投资者关系互动平台"（https://ir.p5w.net） | 形式 网络远程方式 ...

Financial Performance - The company's operating revenue for 2022 was approximately ¥13.41 billion, representing a 37.28% increase compared to ¥9.77 billion in 2021[6]. - The net profit attributable to shareholders for 2022 was approximately ¥663.11 million, a slight increase of 3.14% from ¥642.94 million in 2021[6]. - The total profit reached 784 million yuan, growing by 5.50% compared to the previous year[60]. - Total revenue for 2022 reached ¥13,406,439,368, a year-on-year increase of 37.28% compared to ¥9,765,988,975.7 in 2021[76]. - Health industry revenue surged by 85.77% to ¥937,890,838.57 from ¥504,877,100.88 in 2021, representing 7.00% of total revenue[76]. - The gross profit margin improved to 35%, up from 30% in the previous year, reflecting better cost management[158]. Cash Flow and Investments - The cash flow from operating activities decreased by 31.96% to approximately ¥359.22 million in 2022, down from ¥527.98 million in 2021[6]. - The company achieved a total operating cash inflow of CNY 14.90 billion in 2022, representing a 46.28% increase compared to CNY 10.19 billion in 2021[92]. - The total operating cash outflow was CNY 14.54 billion in 2022, which is a 50.56% increase from CNY 9.66 billion in 2021[92]. - The net cash flow from investing activities was -831,674,790.36, showing an improvement of 18.58% compared to the previous year[93]. - The total investment amount for the reporting period was 265,508,530.00, a decrease of 78.05% compared to the previous year[102]. Dividends and Shareholder Information - The company plans to distribute a cash dividend of 2.5 CNY per 10 shares (including tax) to all shareholders based on the 2022 profit distribution plan[4]. - The cash dividend accounted for 100% of the total profit distribution amount[185]. - The annual shareholders meeting had a participation rate of 54.76% on May 17, 2022[145]. - The company reported a total of 126,000 shares held by the current directors as of July 31, 2023[146]. Research and Development - The company has over 190 ongoing R&D projects, ensuring continuous innovation in product development[47]. - Research and development (R&D) investment amounted to CNY 386.39 million in 2022, a 37.67% increase from CNY 280.65 million in 2021[90]. - The number of R&D personnel increased to 547 in 2022, up 38.48% from 395 in 2021[90]. - The company is developing organic polymer modified materials for applications in the new energy sector, including lithium battery separators and flame-retardant materials[117]. Market Expansion and Strategic Initiatives - The company is expanding into the health and wellness sector through its subsidiary Dongbao Biological, which offers a range of health-related products[33]. - The company is focusing on expanding its presence in the new energy vehicle market, capitalizing on the transformation of energy consumption[51]. - The company plans to expand its market presence in Southeast Asia, targeting a 25% increase in market share within the next two years[164]. - A strategic acquisition of a local competitor is in progress, expected to enhance the company's production capacity by 30%[165]. Risk Management - The company has reported a comprehensive risk assessment in the management discussion and analysis section, highlighting potential future risks and corresponding countermeasures[4]. - The company is exposed to raw material price fluctuations, particularly in the lightweight materials sector, which could impact production costs due to rising oil prices[130]. - The company will continue to enhance internal management and strengthen budget control to mitigate the adverse effects of raw material cost fluctuations[133]. Governance and Management - The company has established a clear governance structure, including a shareholders' meeting, board of directors, and supervisory board, to ensure compliance with legal requirements and effective decision-making[188]. - The management structure includes a general manager responsible for major business decisions, supported by vice presidents and other senior management[189]. - The company has been expanding its management team, with recent appointments aimed at enhancing operational efficiency and strategic direction[149][157]. Environmental Responsibility - The company complied with various environmental protection laws and regulations during its operations[197]. - The company holds valid pollution discharge permits for its subsidiaries, with expiration dates ranging from 2023 to 2028[198]. - The company is committed to environmental responsibility and adheres to industry standards for pollution control[197].

证券代码：002768 证券简称：国恩股份 公告编号：2023-026 青岛国恩科技股份有限公司 关于举办 2022 年度业绩说明会的公告 本公司及董事会全体成员保证信息披露内容的真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 青岛国恩科技股份有限公司（以下简称"公司"）定于 2023 年 6 月 7 日（星 期三）15:00-16:30 在全景网举办 2022 年度业绩说明会，本次年度业绩说明会 将采用网络远程的方式举行，投资者可登陆全景网"投资者关系互动平台" （https://ir.p5w.net）参与本次年度业绩说明会。 青岛国恩科技股份有限公司董事会 2023 年 6 月 3 日 出席本次说明会的人员有：公司董事长兼总经理王爱国先生、公司副总经理 兼财务总监于垂柏先生、公司副总经理兼董事会秘书于雨女士、独立董事王亚平 先生。 为充分尊重投资者、提升交流的针对性，现就公司 2022 年度业绩说明会提 前向投资者公开征集问题，广泛听取投资者的意见和建议。投资者可于 2023 年 6 月 6 日（星期二）17：00 前访问 https://ir.p5w.net/zj/，或扫描下方二维 码，进入问 ...

Financial Performance - The company achieved operating revenue of 13.406 billion yuan, a year-on-year increase of 37.28%[60]. - The total profit reached 784 million yuan, growing by 5.50% compared to the previous year[60]. - Net profit attributable to shareholders was 663 million yuan, reflecting a growth of 3.14% year-on-year[60]. - Total assets amounted to 12.753 billion yuan, an increase of 28.70% from the beginning of the period[60]. - The company's operating revenue for 2022 was ¥13,406,439,368.86, representing a 37.28% increase compared to ¥9,765,988,975.76 in 2021[21]. - The net profit attributable to shareholders for 2022 was ¥663,105,263.13, a 3.14% increase from ¥642,941,542.24 in 2021[21]. - The total operating costs for 2022 were ¥9.98 billion, an increase of 38.72% from ¥7.19 billion in 2021[82]. - The gross profit margin for the chemical industry was 14.12%, a decrease of 1.67% from the previous year[78]. - The company reported a significant increase in sales volume for organic polymer modification materials, rising by 53.18% to 655,813 tons[79]. Research and Development - The company reported a significant focus on research and development for new products and technologies, aiming to enhance market competitiveness[4]. - The company has obtained 78 patents, ensuring a strong foundation for product research and development[47]. - The company is investing in a new project to produce 1 million tons of polystyrene (PS) annually[47]. - The company increased its R&D investment to approximately ¥386.39 million in 2022, up 37.67% from ¥280.65 million in 2021[90]. - The number of R&D personnel rose to 547 in 2022, a 38.48% increase from 395 in 2021[90]. - Research and development expenses increased by 30% in 2022, totaling 150 million yuan, reflecting the company's commitment to innovation[177]. Strategic Investments and Expansion - The company is strategically investing in projects such as a 1 million tons per year polystyrene (PS) project and a 200,000 tons per year polypropylene (PP) resin production line to enhance its competitive edge[38]. - The company aims to enhance its supply chain capabilities and create a diversified "new materials+" ecosystem through vertical integration[38]. - The company is actively pursuing opportunities in the non-metal composite materials sector, capitalizing on the energy consumption transformation[51]. - The company plans to expand its production capacity for expandable polystyrene to 120,000 tons per year in the future[116]. - The company is expanding its market presence, targeting new regions in Southeast Asia, with an investment of 200 million RMB allocated for market entry strategies[152]. Market Trends and Industry Outlook - The new materials industry in China is projected to reach a total output value of ¥10 trillion by 2025, highlighting significant growth potential for the company[34]. - The global chemical new materials market is expected to reach $480 billion by 2025, with a compound annual growth rate (CAGR) of 4.4% from 2019 to 2025[36]. - The domestic health supplement market reached $170 billion in 2021, with China accounting for 19.36% of the global market, making it the fastest-growing region[37]. - The domestic beauty and personal care market size reached ¥390.3 billion in 2021, projected to grow at a CAGR of 8% to ¥577.9 billion by 2026[37]. Corporate Governance - The company emphasizes its commitment to accurate and complete financial reporting, with all board members present for the report's approval[4]. - The management team remains stable with no reported changes in directors or senior management during the reporting period[148]. - The company held five board meetings during the reporting period, with resolutions disclosed in various financial publications[168][169]. - The audit committee conducted 5 meetings, reviewing key reports including the 2021 annual internal audit report and the 2021 audited financial statements[174]. - The company is focused on improving its governance level and operational standards through board oversight[173]. Environmental Compliance - The company strictly adheres to various environmental protection laws and standards during its operations[197]. - The company is classified as a key pollutant discharge unit by environmental protection authorities[197]. - The overall discharge situation indicates no exceedance of the permitted limits for all monitored pollutants[199]. - Future expansion plans include enhancing pollution control technologies to further reduce emissions[200]. Shareholder Returns - The company plans to distribute a cash dividend of 2.5 CNY per 10 shares (including tax) to all shareholders based on the 2022 profit distribution plan[4]. - The company distributed a cash dividend of 2.50 yuan per 10 shares, totaling 67,812,500 yuan, which represents 100% of the profit distribution amount[184][185].

Financial Performance - The company's operating revenue for Q1 2023 was ¥3.614 billion, representing a 32.33% increase compared to ¥2.732 billion in the same period last year[5]. - Net profit attributable to shareholders decreased by 13.08% to ¥102.847 million from ¥118.320 million year-on-year[5]. - The net cash flow from operating activities increased significantly by 233.68%, reaching ¥181.747 million compared to ¥54.467 million in the previous year[5]. - The company reported a 34.47% increase in operating costs, which was attributed to the expansion of its business scale[11]. - The company's basic earnings per share decreased by 13.64% to ¥0.38 from ¥0.44 in the same period last year[5]. - The weighted average return on net assets fell to 2.49%, down from 3.35% year-on-year[5]. - The total operating revenue for Q1 2023 was CNY 3,614,686,083.53, an increase of 32.4% compared to CNY 2,731,566,771.74 in the same period last year[18]. - The total operating costs for Q1 2023 were CNY 3,469,426,680.41, up from CNY 2,576,965,835.34, reflecting a year-over-year increase of 34.6%[18]. - The net profit for Q1 2023 was CNY 126,670,900.24, a decrease of 6.4% from CNY 135,202,641.87 in Q1 2022[19]. - The company reported a gross profit margin of approximately 4.0% for Q1 2023, down from 5.8% in the previous year[18]. - The total comprehensive income for the first quarter was CNY 126,670,900.24, compared to CNY 135,202,641.87 in the previous period, representing a decrease of approximately 3.9%[20]. - The net profit attributable to the parent company was CNY 102,846,682.36, down from CNY 118,320,049.10, reflecting a decline of about 13.1%[20]. - Basic and diluted earnings per share were both CNY 0.38, compared to CNY 0.44 in the previous period, indicating a decrease of approximately 13.6%[20]. Assets and Liabilities - Total assets at the end of the reporting period were ¥13.296 billion, a 4.26% increase from ¥12.753 billion at the end of the previous year[5]. - The total liabilities increased to CNY 7,267,212,809.52, compared to CNY 6,851,756,199.42 in the previous year, indicating a growth of 6.1%[17]. - The equity attributable to shareholders of the parent company rose to CNY 4,175,383,305.97, up from CNY 4,072,100,321.55, reflecting a growth of 2.5%[17]. - The company experienced a 61.74% increase in contract liabilities, primarily due to an increase in customer prepayments[11]. - Accounts receivable increased significantly to CNY 2,015,353,771.60 from CNY 1,589,499,275.70, representing a growth of about 26.8%[15]. - Inventory levels rose to CNY 2,954,644,989.33, up from CNY 2,432,520,065.71, indicating an increase of approximately 21.5%[15]. - Total current assets reached CNY 8,871,760,709.22, compared to CNY 8,433,914,144.66 at the beginning of the year, marking a growth of around 5.2%[15]. - The company’s long-term equity investments increased to CNY 25,881,193.72 from CNY 22,694,547.96, showing a growth of about 14.4%[15]. Cash Flow - As of March 31, 2023, the company's cash and cash equivalents amounted to CNY 2,020,255,201.32, an increase from CNY 1,985,961,969.39 at the beginning of the year, reflecting a growth of approximately 1.7%[15]. - The company’s cash and cash equivalents were reported at CNY 1,143,918,209.45, slightly down from CNY 1,166,336,317.45 in the previous quarter[17]. - Cash inflows from operating activities totaled CNY 3,343,568,858.71, an increase from CNY 3,265,748,860.75, representing a growth of about 2.4%[21]. - The net cash flow from operating activities was CNY 181,746,520.17, significantly up from CNY 54,467,202.61, marking an increase of approximately 234.5%[21]. - Cash outflows for investing activities amounted to CNY 210,307,408.01, compared to CNY 153,883,206.30 in the previous period, an increase of about 36.5%[21]. - The net cash flow from financing activities was negative CNY 9,327,599.03, a decrease from a positive CNY 162,411,833.94 in the previous period[21]. - The ending balance of cash and cash equivalents was CNY 1,260,066,257.38, down from CNY 921,463,887.81, reflecting a decrease of approximately 36.8%[21]. Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 19,529, with the largest shareholder holding 46.45% of the shares[11]. - The company reported a total of 31,500,000 shares held by the controlling shareholder, Wang Aiguo, representing 46.45% of the total shares[13]. - The top ten shareholders include Qingdao Century Star Investment Co., Ltd. with 18,000,000 shares, accounting for 6.64% of the total shares[13]. Research and Development - Research and development expenses rose by 51.66%, indicating increased investment in innovation and personnel[11]. - Research and development expenses increased to CNY 114,336,354.17, representing a 51.7% rise compared to CNY 75,388,045.12 in Q1 2022[18]. Future Outlook - The company plans to continue expanding its market presence and investing in new technologies to drive future growth[19]. - The company’s total assets and liabilities will be further detailed in the upcoming financial reports, indicating ongoing financial assessments and strategic planning[14]. Audit Status - The first quarter report was not audited[22].

证券代码：002768 证券简称：国恩股份 青岛国恩科技股份有限公司投资者关系活动记录表 | --- | --- | --- | |----------------|---------------------------|--------------------------------------------------------| | | √ | 特定对象调研 □分析师会议 | | 投资者关系活动 | □媒体采访 □业绩说明会 | | | 类别 | □ 新闻发布会 □路演活动 | | | | □现场参观 | | | | □ | 其他 （请文字说明其他活动内容） | | 参与单位名称及 | 西南证券 张汪强 | | | 人员姓名 | 2015.11.6 10:30 | | | 时间 | | | | 地点 | 公司会议室 | | | 上市公司接待人 | 董事长、总经理 王爱国 | | | 员姓名 | 副总经理、董事会秘书 刘燕 | | | 投资者关系活动 | | 公司与西南证券张汪强分析师就以下方面进行了沟通和探 | | 主要内容介绍 | 讨： | | | | 1. | 公司简要情况介绍，公司主营业务是什么？ ...

证券代码：002768 证券简称：国恩股份 青岛国恩科技股份有限公司投资者关系活动记录表 | --- | --- | --- | |-----------------------|-------------------------------------------------|------------------------------------------------------| | | √ | 特定对象调研 □分析师会议 | | 投资者关系活动 | □媒体采访 □业绩说明会 | | | 类别 | □ 新闻发布会 □路演活动 | | | | □现场参观 | | | | □ | 其他 （请文字说明其他活动内容） | | 参与单位名称及 | 中国国际金融股份有限公司 李璇 | | | 人员姓名 | 2015.12.22 10:30 | | | 时间 | | | | 地点 | 公司会议室 | | | 上市公司接待人 员姓名 | 董事长、总经理 王爱国 副总经理、董事会秘书 刘燕 | | | 投资者关系活动 | | 公司与中金公司研究部李璇经理就以下方面进行了沟通和探 | | 主要内容介绍 | 讨： | | ...

证券代码：002768 证券简称：国恩股份 | --- | --- | --- | |----------------|---------------------------|--------------------------------------------------------| | | √ | 特定对象调研 □分析师会议 | | 投资者关系活动 | □媒体采访 □业绩说明会 | | | 类别 | □ 新闻发布会 □路演活动 | | | | □现场参观 | | | | □ | 其他 （请文字说明其他活动内容） | | 参与单位名称及 | 东方证券 倪吉 | | | 人员姓名 时间 | 2015.11.11 10:30 | | | 地点 | 公司会议室 | | | 上市公司接待人 | 董事长、总经理 王爱国 | | | 员姓名 | 副总经理、董事会秘书 刘燕 | | | 投资者关系活动 | | 公司与东方证券石油化工行业研究员倪吉就以下方面进行 | | 主要内容介绍 | 了沟通和探讨： | | | | 1. | 公司主营业务是什么？主要产品及种类有哪些？主要应用 | | | 于哪些领域？ | | | ...